Author:
Crystal Owen,Maralani Pejman J.,Black Sandra,Fischer Corinne,Moody Alan R.,Khademi April
Funder
Alzheimer Society
Government of Ontario
Natural Sciences and Engineering Research Council of Canada
Subject
Cognitive Neuroscience,Neurology (clinical),Neurology,Radiology, Nuclear Medicine and imaging
Reference63 articles.
1. Alzheimer’s Association. (2023). Alzheimer’s Disease Facts and Figures. Alzheimers Dement, 19(4), doi 10.1002/alz.13016.
2. Increasing CSF phospho-tau levels dur- ing cognitive decline and progression to dementia;Andersson;Neurobiol. Aging,2008
3. Badhwar, A., McFall, G. P., Sapkota, S., Black, S. E., Chertkow, H., Duchesne, S., Masellis, M., Li, L., Dixon, R. A., & Bellec, P. (2020). A multiomics approach to heterogeneity in Alzheimer’s disease: Focused review and roadmap. Brain, 143(5), 1315–1331. https://doi.org/10. 1093/brain/awz384.
4. FLAIR MRI biomarkers of the normal appearing brain matter are related to cognition;Bahsoun;Neuroimage Clin.,2022
5. Understanding white matter disease: imaging- pathological correlations in vascular cognitive impairment;Black;Stroke,2009